Trial intelligence / Profile preview

Riluzole for acute spinal cord injury

IRCT2014031813947N3Phase 2Completed

Sponsor
Tabriz University of Medical Sciences
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of riluzole in acute spinal cord injury (SCI), sponsored by Tabriz University of Medical Sciences. Started Mar 2014; status: completed.

02

Drugs

riluzole
03

Conditions

acute spinal cord injury (SCI)

Beyond the preview

Go deeper on IRCT2014031813947N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2014031813947N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call